Image de couverture de livre

Response to “Misuse of the Term Biorhythms Undermines Chronological Research”

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	William J. Jusko
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Clinical Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Misuse of the Term Biorhythms Undermines Chronobiological Research
par: Yvan Touitou
Publié: (2025)

Insights Into Aldosterone Regulation Through Pharmacokinetic–Pharmacodynamic Modeling of an Aldosterone Synthase Inhibitor
par: Javiera Cortés‐Ríos, et autres
Publié: (2025)

The Rising Misuse of Pharmacovigilance Reporting Systems: A Threat to Evidence‐Based Medicine
par: Charles Khouri, et autres
Publié: (2025)

Hepatitis B In Silico Trials Capture Functional Cure, Indicate Mechanistic Pathways, and Suggest Prognostic Biomarker Signatures
par: Javiera Cortés‐Ríos, et autres
Publié: (2025)

Population Pharmacokinetics of Clesrovimab in Preterm and Full‐Term Infants
par: Ziheng Hu, et autres
Publié: (2026)

Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
par: Ko‐Hsiu Lu, et autres
Publié: (2026)

Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS
par: Carlotta Bidoli, et autres
Publié: (2025)

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans
par: Guang Yang, et autres
Publié: (2025)

Quantitative Lesion‐Level Modeling Reveals Organ‐Dependent Therapeutic Response
par: Ian Dilley, et autres
Publié: (2026)

Exposure‐Response Relationships for Axatilimab in Patients with Chronic Graft‐Versus‐Host Disease
par: Yan‐ou Yang, et autres
Publié: (2025)

Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
par: Sumit Bhatnagar, et autres
Publié: (2024)

Evaluating the Effect of Estimating Renal Function With the CKD‐EPI 2021 Equation on the ABCD‐GENE Score for Clopidogrel Response Prediction
par: Maryam Jamal AlSaeed, et autres
Publié: (2024)

Population Pharmacokinetic and Exposure–Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis
par: Neha Thakre, et autres
Publié: (2024)

Attaining Equity of Access to Research: Perspective on Research in Pregnancy and Breastfeeding Following Dolores Shockley Lecture at ASCPT2024
par: Catriona Waitt, et autres
Publié: (2024)

Response to Letters Regarding “Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors”
par: Léonard Laurent, et autres
Publié: (2025)

Exposure–Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple‐Negative Breast Cancer
par: Abhishek G. Sathe, et autres
Publié: (2024)

Population Pharmacokinetics and Exposure–Response Analysis of a Fixed‐Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults
par: Jaime Algorta, et autres
Publié: (2024)

Optimizing Brentuximab Vedotin Dosing in Pediatric Patients with Advanced Hodgkin Lymphoma: A Population Pharmacokinetic and Exposure‐Response Analysis
par: Xiaofei Zhou, et autres
Publié: (2025)

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis
par: Benjamin Rich, et autres
Publié: (2025)

Population Pharmacokinetics and Exposure‐Response Analysis of First‐Line Osimertinib Plus Chemotherapy in Patients with EGFR ‐Mutated Advanced NSCLC
par: Jincheng Yang, et autres
Publié: (2025)

Disentangling Anti‐Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab
par: Aymara Sancho‐Araiz, et autres
Publié: (2024)

Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure–Response Models, and Real‐World Patient Data
par: Yuli Qian, et autres
Publié: (2024)

Home Is Where the Research Is: The Promise of Decentralized Clinical Trials
par: Sarah A. Holstein
Publié: (2025)

A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure–Response Relationship during Treatment of Obesity with Tirzepatide
par: Emmanuel Chigutsa, et autres
Publié: (2025)

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation
par: Yoo Jin Jang, et autres
Publié: (2024)

Untargeted Metabolomics Identifies N‐Lactoyl‐Amino Acids as Dose‐Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes
par: Tomas Cajka, et autres
Publié: (2026)

Population Pharmacokinetic Modeling and Exposure–Response Analysis for the Antibody–Drug Conjugate Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Carcinoma
par: Peiying Zuo, et autres
Publié: (2024)

Corrigendum: “Comparative Effectiveness of Bimekizumab in Psoriatic Arthritis: A Model‐Based Meta‐Analysis of American College of Rheumatology Response Criteria”
Publié: (2024)

Community Partnerships in Clinical Research: A Framework for Sustainability and Resilience
par: Shayna R. Killam, et autres
Publié: (2026)

Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses
par: Thomas M. Polasek, et autres
Publié: (2024)

Ongoing Pharmacological Developments in SLC6A1 Research & Treatment
par: Melissa B. DeLeeuw, et autres
Publié: (2024)

Longitudinal Tumor Size and Survival Modeling for Exposure–Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer
par: Emmanuel Chigutsa, et autres
Publié: (2026)

A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin
par: Pablo Lapuerta, et autres
Publié: (2024)

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
par: Karthik Venkatakrishnan, et autres
Publié: (2025)

Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.gov
par: Lars Masanneck, et autres
Publié: (2024)

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real‐World Evidence
par: Rohini K. Hernandez, et autres
Publié: (2025)

Liberty on Odaiba, Against the Silhouette of Tokyo Bay: Inspirations for Moving Hypothesis‐Generating Research to Patient‐Centered Therapeutics
par: Karthik Venkatakrishnan
Publié: (2026)

Application and Quality of Model‐Based Meta‐Analysis in Pharmaceutical Research: A Systematic Cross‐Sectional Analysis and Practical Considerations
par: Zhirong Yang, et autres
Publié: (2024)

A White Paper on Advancing Long‐Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation
par: Moherndran Archary, et autres
Publié: (2026)

Uncovering Coenzyme Q10 ‐Related Genetic Determinants of Statin‐Associated Muscle Symptoms: Evidence from the UK Biobank and the All of Us Research Program
par: Da Hoon Lee, et autres
Publié: (2026)